Please explain further? What type of person confirmed this (position in the company) or is it from posters on online boards? I just have doubts this stuff goes public before JT/amarin announces
BB or Danchicago, Isnt that common for a bio stock prior to fda approval? I was reading that is a common practice. Doesn’t necessarily mean something is imminent like approval or a BO, rather some companies chose to implement this so there is no appearance of impropriety, sort of like the blackout period before earnings release. Could this just have a simple explanation? Dan, is this common?
You might ask them if they had a blackout period when reduce-it results were being analyzed. Before they were released. I would bet they did. It may just be that they are starting to have conversations with the FDA regarding approval and they do not want any risk of impropriety.